Pre-surgery postbiotic pill may cut colon cancer operation risks

NCT ID NCT07268846

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether taking a postbiotic supplement (butyrate) for 7 days before colorectal cancer surgery can lower the chance of complications like infections or bowel issues. Researchers will compare complication rates in 164 adults who get the supplement versus those who don't. The goal is to see if this simple, low-cost approach can make recovery safer.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
butyrate (a postbiotic dietary supplement)
What this could lead to
If it works, this could point toward a simple, low-cost way to lower complication rates after colorectal cancer surgery.
What could go wrong
This is a small, early-stage trial testing a dietary supplement. The effect on complications may be small or absent, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER (COLON CANCER, BREAST CANCER, LYMPHOMA, CHRONIC LYMPHOMA LEUKEMIA, MULTIPLE MYELOMA) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • A.C.Camargo Cancer Center

    RECRUITING

    São Paulo, São Paulo, 01509-010, Brazil

More trials for these conditions

Other studies related to the condition(s) this trial covers.